This activity is expired and is no longer available for CME credit.


Emerging Science in Advanced Age-related Macular Degeneration: Assessing New Evidence for Classification and Treatment

Author(s)/Faculty: Brandon G. Busbee, MD; SriniVas R. Sadda, MD; Rishi P. Singh, MD; Giovanni Staurenghi, MD
Release Date: 12/14/2016Expiration Date: 12/13/2018
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
Age-related macular degeneration (AMD) is a deterioration or breakdown of the eye's macula. At present, pharmacotherapy is available only for late neovascular AMD. However, the AREDS and AREDS 2 studies have demonstrated a substantial reduction in the risk of progression to the advanced forms of the disease in patients taking antioxidant supplements. The prospect of effective therapies in the near future, together with an increasing incidence of AMD in an aging population, has led to increased interest in early, accurate diagnosis and classification of AMD, as well as medications to effectively treat it. This educational program will address imaging techniques and technology, evidence for optimizing treatment regimens and visual aids, as well as the potential clinical utility of emerging treatments for early-to-late AMD.